LATEST MEDICAL CANNABIS STOCK NEWS

IM Cannabis announces Focus Medical's Import of 400 Kilograms of Premium-Indoor-Grown Dried Cannabis from Canada to Israel
The successful import demonstrates the strength of the IM Cannabis global supply chain and business model TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / January 19, 2022 / IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC)(NASDAQ:IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany is pleased to announce that Focus Medical Herbs Ltd. ("Focus... Read more
Martha Stewart CBD Launches its First-Ever Category Expansion with New Line of CBD Wellness Topicals
New Super Strength CBD Cream, Sleep Science CBD Cream and Daily De-Stress CBD Cream Add to Martha's Wellness Portfolio ­­SMITHS FALLS, ON and NEW YORK, Jan. 19, 2022 /CNW/ - Today, Martha Stewart CBD unveiled Martha Stewart CBD Wellness Topicals, marking the brand's first-ever category expansion in its growing CBD portfolio. Martha Stewart CBD provides consumers with an easy way to manage their... Read more
1933 Industries Announces Partnership Between Day One Beverages and USA Pickleball Association
Leading CBD Drinks Brand Aligns with USA's Fastest Growing Sport, Keeping Players Refreshed and Revitalized 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF) (OTCQB:TGIFF), a Nevada-focused cannabis consumer packaged goods company, is pleased to announce that Day One Beverages, Inc. ("Day One") has been named the exclusive and "Official CBD Partner of USA Pickleball", America's fastest growing sport, for... Read more
AREV SAB member Richard Van Breeman PhD publishes landmark study on CoVid19
AREV LIFE SCIENCES GLOBAL CORP. (CSE:AREV) (CNSX:AREV.CN) (OTC:AREVF) (“AREV” or the “Company”) is pleased to announce a recent study by Richard Van Breeman PhD, a member of AREV’s Scientific Advisory Board (SAB), along with collaborators at Oregon State University’s (OSU) College of Pharmacy, the Linus Pauling Institute and OSU’s Global Hemp Innovation Center, published in the January edition of the Journal of... Read more
PURA Aims To Modestly Extract $10 Million This Year From $18 Billion Hemp Industry Establishing A Foothold In A Much Larger Opportunity
Puration, Inc. (OTC Pink: PURA) today published a 2022 strategic management overview of the company’s plan for an anticipated $1 million in revenue with the potential to reach $10 million in revenue this year. The overview published today will be followed up over the next several weeks with additional management presentations covering more detail on each of the major overview components highlighted in the presentation... Read more
WEED, Inc. BUILDING DREAMS: Westfield, New York Town Council Approves Adult Use & Medical Cannabis as WEED Makes Plans to Enter the New York Cannabis Marketplace
WEED is exploring possibility of building out our 43 acre Sugar Hill Golf Course in Westfield, NY into: The 4 Winds Luxury Condos & Villas Resort- Cannabis friendly! WEED, Inc. (OTCQB:BUDZ) ("WEED" or the "Company"), a cannabis and hemp bioresearch company based in the USA, announced in December that it completed the purchase of the Sugar Hill Golf Course in Westfield, New York making the Final Payment of ~$250,000... Read more
Green Stock News
Item 9 Labs Corp. Reports Record FY 2021 Annual Financial Results with Revenue Growth of 170% to $21.9 Million Revenue
 Item 9 Labs Corp. (OTCQX: INLB) (the "Company")—a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-winning products—today reported operating and financial results for the 12 months ended September 30, 2021, the Company's fiscal year 2021 ("FY2021"). Item 9 Labs Corp. management will be hosting an earnings results call today, January 18, at 2:00... Read more
SciSparc Advances Its Phase IIb Clinical Trial in Patients with Tourette Syndrome with its Proprietary Drug Candidate SCI-110
SciSparc Ltd. (NASDAQ: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the "Company" or "SciSparc"), today announced that it has entered into an agreement with two clinical sites: Hannover Medical School in Hannover, Germany, and Tel-Aviv Sourasky Medical School, in Tel-Aviv, Israel, to further its Phase IIb clinical study... Read more
Novamind Closes Arizona Acquisition
Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, announces that, further to its press release dated December 23, 2021, it has closed its acquisition (the "Acquisition") of Arizona-based Foundations for Change, Inc. ("Foundations"), a mental health practice specialized in ketamine-assisted psychotherapy. "We're thrilled to welcome... Read more
1933 Industries Signs Binding Letter of Intent to Acquire Beverage Company Day One
1933 Industries Signs Binding Letter of Intent to Acquire Beverage Company Day One 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF) (OTCQB:TGIFF), a Nevada-focused cannabis consumer packaged goods company, is pleased to announce that it has entered into a binding Letter of Intent ("LOI") to acquire 100% of all of the authorized and issued shares of Day One Beverages, Inc. ("Day One"), a disruptive... Read more
Medical Marijuana, Inc. Subsidiary Kannaway® Hires Jeanne Rawdin to Lead Company's Global Communications
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiaryKannaway® has hired Jeanne Rawdin as the Company’s Global Communications Manager. Rawdin joins Kannaway® after establishing a successful career in... Read more
Cannabis Industry Investor Conference: Company Executives Present January 19th & 20th
Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the agenda for the upcoming Cannabis Industry Virtual lnvestor Conference. Individual investors, institutional investors, advisors and analysts are invited to attend. The two-day program begins at 11:00 AM ET on Wednesday, January 19th. It is recommended that investors pre-register and run the online system check to expedite... Read more
Columbia Care Welcomes Derek Watson as Chief Financial Officer
Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of medical and adult-use cannabis products in the United States, has hired Derek Watson as Chief Financial Officer. Derek brings more than 30 years of finance and leadership experience to the role, including in strategy, investor... Read more
Innocan Pharma Announces the Inauguration of Its Drug Development Lab at Biohouse in the Hadassah Medical Center in Jerusalem
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce that it has inaugurated its first and new drug research and development lab at Biohouse Labs at Hadassah Medical Center in Jerusalem to accelerate the Company's liposome Platform Technology (LPT) development. The Company's development program is focused on improving and optimizing LPT characterization methods... Read more
IM Cannabis Corp. Appoints Rinat Efrima as New Chief Executive Officer of IMC Holdings, the Company’s Israeli Subsidiary
Oren Shuster remains Chief Executive Officer and Director of IM Cannabis Corp.; other managerial changes include the promotion of Yael Harrosh to Chief Legal and Operations Officer of IM Cannabis Corp. IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC) (NASDAQ:IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany today announced the appointment of... Read more
Novamind Hosts Pioneering Psychedelic Clinical Trial for Opioid Use Disorder
Novamind Inc. (CSE:NM) (OTCQB:NVMDF) (FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today announced it will host a phase I randomized clinical trial for adults with opioid use disorder. The study will investigate the safety and efficacy of ketamine-assisted psychotherapy combined with Mindfulness-Oriented Recovery Enhancement therapy (the "MORE+KAP Clinical... Read more
Innocan Pharma to Expand its LPT Platform to the Veterinary Field
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is pleased to announce a second amendment (the "Amendment") to the research and license agreement with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. ("Yissum") for the performance of studies evaluating the efficacy of its CBD-Loaded Liposome Platform Technology (LPT) in treating dogs. The Amendment... Read more
Settlement Reached in Tietz Class Action Lawsuit
PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce the settlement of the proposed class action filed by Michael Tietz and Duane Loewen against the Company and many other parties in B.C. Supreme Court Action No. S197731, Vancouver Registry (the "Action"). PreveCeutical commenced its own action against some of the defendants to the Action... Read more
Medical Marijuana, Inc. Subsidiary Kannaway® Opens New Office and Warehouse in Warsaw, Poland
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary Kannaway® has opened a new office and warehouse in Warsaw, Poland. The new 7,771 square foot warehouse is strategically positioned near the... Read more
PharmaTher Announces FDA Approval of Investigational New Drug (IND) Application for Ketamine to Treat ALS
PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a company focused on the development and commercialization of specialty ketamine prescription-based products, today announced that the U.S. Food and Drug Administration (“FDA”) has accepted an investigator-initiated investigational new drug ("IND") application to proceed with a Phase 2 clinical trial (the “Study”) evaluating... Read more
JTC Team to Host Virtual Investor 2022 Top Picks Conference on January 25th, 26th, and 27th
Access the event and schedule of presenting companies at virtualinvestorco.com  Live video webcast presentations of participating companies followed by interactive Q&A session  JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announced it will host the Virtual Investor 2022 Top Picks Conference January 25-27, 2022. As part of the virtual event, JTC partnered... Read more
Green Stock News
SciSparc Exploring Psychedelics as Possible Avenue to Expand Its IP Portfolio
SciSparc Ltd. (NASDAQ: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the "Company"), announced that it has begun to examine the possibility of including psychedelic compounds as potential drug candidates for its intellectual property portfolio. Despite being heavily regulated around the world, psychedelics have... Read more
Green Stock News
CV Sciences, Inc. Announces Launch of +PlusCBD™ Pain Relief Topicals
CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (“CBD”) products, today announced the launch of +PlusCBD™ Pain Relief topicals: four unique Over-the-Counter (“OTC”) products formulated to pinpoint sources of minor pain and aches using active ingredients including warming camphor and cooling... Read more
Gb Sciences Completes $8 Million Sale of Las Vegas Cannabis Facility
Gb Sciences, Inc. (OTCQB:GBLX), a leading plant-inspired, biopharmaceutical research and development company, has closed the sale of its last remaining cannabis facility, completing a transition to the biopharmaceutical industry.  "This is a landmark event for Gb Sciences," said Chairman and CEO John Poss. "We have emerged from this sale as a pure-play biopharmaceutical research and development company. With an... Read more
Emerald Health Therapeutics Sells Patents to FlowerPod
Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has entered into a binding term sheet to sell to FlowerPod LLC all patents and related intellectual property pertaining to Emerald's vaporizer cannabis puck concept in exchange for US$1 million in cash and a US$500,000 one-year interest-bearing secured promissory note. As part of the transaction, Emerald will transfer its ownership interest back to... Read more
Organigram Reports First Quarter Fiscal 2022 Results
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the first quarter ended November 30, 2021 (“Q1 Fiscal 2022”). “Our record-breaking results in the first quarter of Fiscal 2022 are a testament to our successful strategy to create innovative, high-quality products... Read more
Green Stock News
Item 9 Labs Corp. to Host its Fiscal Year 2021 Earnings Call on January 18 at 2 p.m. ET
Item 9 Labs Corp. (OTCQX: INLB) (the "Company")—a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-winning products—announced today that it will host a conference call on Tuesday, January 18, 2022 to discuss financial results for its fiscal year 2021, ended September 30, 2021. The 10K will be filed on Thursday, January 13, 2022. Item 9 Labs Corp.... Read more
Levitee Labs Partners with Canntab Therapeutics to Provide Alternatives to Opioids
The agreement is anticipated to contribute to correcting the opioid crisis in Canada and serve as a foundation for both companies to potentially expand into new verticals in the future Levitee Labs and Canntab Therapeutics have executed a services agreement resulting in Levitee Labs informing patients about the Canntab portfolio of therapeutics Levitee Labs will offer the entire Canntab product lineup throughout all its... Read more
Tilray, Inc. Reports Profitable Second Quarter Fiscal Year 2022 Financial Results
Net Revenue Increased ~20% to $155 Million from the Prior Year Quarter Net Income Improved $95 Million to $6 Million from the Prior Year Quarter Adjusted EBITDA of $13.8 Million, 11th Consecutive Quarter of Positive Adjusted EBITDA Achieved $70 Million in Cost Synergies To Date; On-Track to Exceed Original Plan of $80 Million Ahead of Schedule and to Generate Additional $20 Million of Synergies in Fiscal... Read more
Green Stock News
Canntab Delivers 1st Shipment To The Ontario Cannabis Store And 2nd Shipment To Australia
Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to provide an update on its recent product deliveries for Ontario and Australia. On January 7, 2022 Canntab completed its first shipment of 5 mg THC tablets to the Ontario Cannabis... Read more
Skye Bioscience Issues Shareholder Letter Providing Progress Update and Business Outlook for 2022
Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a pharmaceutical company developing proprietary, synthetic, cannabinoid-derived molecules to treat diseases with significant unmet need, issued today the following letter from Chief Executive Officer and Chair, Punit Dhillon. Dear Shareholders, Colleagues and Collaborators, I would like to thank you for your steadfast support and dedication in bringing our novel... Read more
Dara Redler to Join H&R Block as new Chief Legal Officer
H&R Block (NYSE: HRB) today announces that Dara Redler is joining the company as Chief Legal Officer, as current General Counsel and Chief Administrative Officer Tom Gerke announces his retirement after serving the company for the past 10 years. Redler previously served as General Counsel and Corporate Secretary for Tilray, Inc. (NASDAQ: TLRY). She was the first general counsel for the global cannabis business where she... Read more
Love Hemp Group PLC Announces Notice of General Meeting
Love Hemp Group PLC (AQSE:LIFE) (OTCQB:WRHLF), the brand-led consumer goods company focussed on CBD health and wellness solutions, gives notice that a General Meeting ("GM") will be held on 4 February 2022 at 10 am at 48 Warwick Street, London, W1B 5AW. At the meeting, resolutions will be proposed to receive and adopt the 30 June 2021 annual accounts and to approve the reduction of the share premium account of the Company as... Read more
Green Stock News
SciSparc Announces Recruitment of First Patient for its Phase IIa Clinical Trial in Alzheimer's Disease
SciSparc Ltd. (NASDAQ: SPRC) (the "Company"), a clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced that The Israeli Medical Center for Alzheimer's has recruited the first patient to participate in the Company's Phase IIa clinical trial that will evaluate the safety, tolerability and efficacy of SCI-110 in patients with Alzheimer's... Read more
Zynerba Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference
Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced that Armando Anido, Chairman and Chief Executive Officer of Zynerba Pharmaceuticals, will present during the H.C. Wainwright BioConnect Conference being held virtually January 10-13, 2022. A webcast of the presentation will be... Read more
Columbia Care Announces Commencement of Noteholder Consent Solicitation to Increase Debt Capacity
Columbia Care Inc. (NEO: CCHW) (CSE:CCHW) (OTCQX:CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the United States, today announced that it is commencing a solicitation of consents (the “Consent Solicitation”) from holders (“Noteholders”) of its 13.00% senior secured notes due May 14, 2023; 5.00%... Read more
Entourage Health Posts New Year 2022 Shareholder Newsletter
Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products and brands issued an open letter to shareholders today to provide a recap of its corporate and operational achievements attained over the past year, and an overview of what is expected in 2022. The Company overview and Shareholder... Read more
Novamind Unveils New Design Concept for Clinics
Novamind Inc. (CSE:NM) (OTCQB:NVMDF) (FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today unveiled its clinic design concept (the "Design Concept") to accommodate the unique requirements of psychedelic-assisted psychotherapy. The Design Concept will launch first in Novamind's Park City, Utah location, and later across Novamind's de novo clinics. Select design... Read more
Green Stock News
Canopy Growth Issues Environmental, Social, and Governance Report
The inaugural report details the Company's commitment to building a responsible and sustainable organization defined by purpose Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) today announced the release of its Environmental, Social, and Governance (ESG) Report ("the Report") for calendar year 2020, as well as qualitative details on some key activities that occurred in 2021.  The... Read more
Green Stock News
CV Sciences, Inc. Announces New Distribution Agreement with GNC
CV Sciences, Inc. (OTCQB: CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced a major new distribution agreement with GNC. Beginning in early 2022, consumers will be able to purchase the Company’s top selling ingestible products under the +PlusCBD™ brand in 770 GNC locations. The initial product... Read more
MediPharm Labs Completes Payment of All Convertible Debt
MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce that it has completed all payments required under its 2020 $41 million unsecured convertible debt. “MediPharm continues on its plan and path to profitability, and paying off our convertible debt in full is a major milestone on... Read more
Organigram to Report First Quarter Fiscal 2022 Results on January 11, 2022
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2022 ended November 30, 2021 on Tuesday, January 11, 2022 before market open. The Company will host a conference call to discuss its results with details as... Read more
Zynerba Pharmaceuticals Announces Clinical Development Updates for FXS, ASD, 22q and DEE
Company plans to focus development of Zygel™ in FXS, ASD and 22q  Company plans to initiate Phase 3 trial with Zygel in ASD in the second half of 2022  Zynerba to hold conference call tomorrow, January 5, 2022 at 9:00 a.m. ET  Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric... Read more
Medical Marijuana, Inc. Subsidiary Kannaway® Celebrates New Milestone; Achieves Best Revenue Month in Company History for Japan Division in December 2021
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary Kannaway® Japan had its best revenue month in the Company’s history in December 2021. According to Research and Markets, the global CBD oil market is... Read more
Green Stock News
Item 9 Labs Corp. Enhances Board of Directors with Two Independent Appointments
 Item 9 Labs Corp. (OTCQX: INLB) (the "Company")—a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-winning products—announced today that Eric C. Kutscher, Pharm. D., M.B.A., F.A.S.H.P., and Lawrence X. Taylor have been appointed to its Board of Directors. "Eric and Lawrence have vastly different backgrounds that will enrich our foundation across several... Read more
Green Stock News
SciSparc Issued U.S. Patent For Its Core Technology That Treats Central Nervous Systems Disorders
SciSparc Ltd. (NASDAQ: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the "Company" or "SciSparc"), marks today one of the Company's most important milestones to date - the U.S. Patent and Trademark Office has granted it a new patent - U.S. Patent No. 11,207,290, titled combinations of cannabinoids and n-acylethanolamines... Read more
Green Stock News
Mandatory Insurance Coverage for Medical Cannabis Now Expands to More than 50 million Colombians
Starting January 1st, 2022, every insurance provider in Colombia, is now mandated to cover the costs of high and low THC medical cannabis prescriptions Significantly improves the current insurance coverage process, simplifying the procedure and reducing approval times for patients to obtain insurance coverage across the country Colombia has upwards of 6 million potential patients for medical cannabis products (Source:... Read more
Green Stock News
Aurora Cannabis Delivers ~$10 Million Shipment of Medical Cannabis to Israel
• Believed to be the largest shipment of medical cannabis to Israel to-date • Aurora continues to advance strategic leadership in the global cannabinoid industry Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the delivery of a cannabis shipment worth approximately C$10 million - the company's largest ever... Read more
PharmaTher Announces Publication of Research Data for KETABET™
Second published study to demonstrate the potential therapeutic utility and mechanism of action of KETABET™ (patented combination of ketamine and betaine) in models of depression Repeated use of KETABET™ exhibits potential protective and reversing effects on ketamine-elicited psychotomimetic behaviors and cognitive impairments Supports clinical initiatives as a potential next generation ketamine treatment for mental... Read more
Aurora Cannabis Announces New Director and Updates to The Board
Newly created directorship to be filled by Chitwant Kohli, Senior Financial Executive Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the appointment of Chitwant Kohli to the Company's Board of Directors (the "Board"), effective today. This is a newly added... Read more
Aleafia Health Provides Update on the Negotiation of its Convertible Debt
Aleafia Health Inc. (TSX: AH, AH.DB, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is providing a corporate update regarding its outstanding listed unsecured convertible debentures (TSX: AH.DB), issued on June 27, 2019 and maturing on June 27, 2022 (the “Convertible Debt”). The Company has initiated negotiations with debenture holders with a view of amending the Convertible Debt to achieve an outcome that is... Read more
Skye Bioscience to Present at H.C. Wainwright BIOCONNECT Virtual Conference
Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a biopharmaceutical company developing proprietary, synthetic, cannabinoid-derived molecules to treat diseases with significant unmet need, announced today that it will present a corporate overview at the H.C. Wainwright BIOCONNECT Conference, held virtually January 10-13, 2022. Punit Dhillon, Chief Executive Officer and Chair, will be presenting an on-demand presentation... Read more
Columbia Care Opens its 80th Dispensary with New Cannabist Location in Virginia Beach
Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the U.S., announced today the opening of Cannabist Virginia Beach, its fourth dispensary in the Commonwealth and 23rd Cannabist nationwide, located at 535 N Birdneck Road. “Virginia’s demand for high quality... Read more
Cronos Group Provides Bi-Weekly MCTO Status Update
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”). On November 9, 2021, the Company announced that it applied for a management cease trade order (“MCTO”) with the applicable securities regulatory... Read more
Emerald Health Therapeutics Reports 2021 AGM Results
Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has announced the results of voting at its annual general meeting held December 30, 2021. Shareholders voted in favour of all resolutions, setting the number of directors at three, electing Jim Heppell, Punit Dhillon and Bobby Rai as directors, and appointing MNP LLP as auditors of the Company for the ensuing year and authorizing the directors to fix... Read more
Love Hemp Group PLC Announces Result of AGM and Total Voting Rights
Love Hemp Group PLC (AQSE:LIFE) (OTCQB:WRHLF), the brand-led consumer goods company focussed on CBD health and wellness solutions, is pleased to announce that all resolutions were duly passed at the Annual General Meeting of the Company held today. Total Voting Rights For the purposes of the Financial Conduct Authority's Disclosure Guidance and Transparency Rules, Love Hemp announces that the Company has 942,248,881... Read more
Green Stock News
PharmaCielo Completes Initial Tranche of Non-Brokered Private Placement of Debenture Units
All amounts expressed in Canadian dollars unless otherwise noted PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. ("Holdings"), is pleased to announce that it has closed the first tranches of its previously announced non-brokered private placement (the... Read more
1933 Industries Reports First Quarter 2022 Financial Results
1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF) (OTCQB:TGIFF), a Nevada-focused cannabis consumer packaged goods company, is pleased to announce its first quarter ("Q1 2022") financial results for the three months ended October 31, 2021. All amounts expressed are in Canadian dollars. Financial statements are prepared in accordance with International Financial Reporting Standards (IFRS). Detailed... Read more
Lotus Ventures Inc. Reports Fiscal 2021 Results
Lotus Ventures Inc. (CSE: J) (OTC: LTTSF) (“Lotus” or the “Company”), a trusted cannabis producer in Canada is pleased to report its Fiscal 2021 full year results and a second consecutive year reporting a profit for the year ended August 31, 2021. Full year revenue increased to $5.4 million up 18 percent compared to the prior year.   Fourth quarter revenue of $1.2 million, a decrease compared to the prior... Read more
Green Stock News
SciSparc Provides Updates Upon Conclusion of 2021
SciSparc Ltd. (NASDAQ: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the "Company" or "SciSparc"), today provides updates regarding its activities in 2021. Itzhak Shrem, Chairman of the board of SciSparc, said, "We are excited to conclude a very eventful and successful year. We reached several important milestones,... Read more
Aleafia Health Announces Closing of a New $19 Million Credit Facility and Extension of Existing Credit Facility
Credit Facility provides the Company with liquidity to fund operations and organic growth initiatives Two-year term provides additional financial flexibility Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the closing of a credit facility of up to $19 million (the “Credit Facility”). “This financing improves our liquidity and capital structure as the... Read more
Entourage Health and LiUNA Pension Fund Upsize Credit Facility with Additional $20 Million in Non-Dilutive Financing
Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products and brands, announced today it has amended its existing credit facility (“Credit Facility”) with an affiliate of the LiUNA Pension Fund of Central and Eastern Canada (“LPF”) to add an additional $20 million in non-dilutive... Read more
Love Hemp Group PLC Announces Issue of Equity
Love Hemp Group PLC (AQSE:LIFE) (OTCQB:WRHLF), one of the UK's leading CBD and Hemp product suppliers, announces the issue of shares. As announced on 3 February 2021, the Company and the vendors of Love Hemp Limited (the "Vendors") agreed that settlement of the final deferred consideration of £2,000,000 due to the Vendors was to be satisfied by the issue of ordinary shares of 1p each in the Company ("Ordinary Shares"),... Read more
AREV Life Sciences appoints Allan Echino as Director and Denby Greenslade as interim CFO
AREV LIFE SCIENCES GLOBAL CORP. (CSE:AREV) (CNSX:AREV.CN) (OTC:AREVF) (“AREV” or the “Company”) is pleased to announce the appointment of Allan Echino as Director effective December 21, 2021 and Denby Greenslade as interim Chief Financial Officer (“CFO”), effective December 17, 2021. Allan Echino began his entrepreneurial experience as a youngster, working in the family business in Kamloops, BC.  As well as... Read more
Novamind Signs Definitive Agreement to Acquire Arizona-based Clinics
Novamind Inc. (CSE:NM) (OTCQB:NVMDF) (FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, has signed a definitive agreement (the "Agreement") to acquire Arizona-based Foundations for Change, PLC ("Foundations"), a mental health practice specialized in ketamine-assisted psychotherapy, from its sole stockholder, Jeff Edelman, (the "Seller"). The transaction (the... Read more
Love Hemp Group PLC Announces Launch of Deliveroo Tie Up in London
Love Hemp Group PLC ("Love Hemp" or the "Company") (AQSE:LIFE) (OTCQB:WRHLF), the brand-led consumer goods company focussed on CBD health and wellness solutions, is pleased to announce it has launched, on a trial basis, with Deliveroo, the on-demand delivery service. A Love Hemp virtual store with the Company's full range of products is now live on Deliveroo. This initial launch is considered a trial by the Company to gauge... Read more
CannAmerica clarifies terms of acquisition of Arsenal Oils & Extracts in Colorado
CannAmerica Brands Corp. (CSE:CANA) (CNSX:CANA.CN) (OTC:CNNXF) ("CannAmerica" or the "Company”) further to the Company’s news release dated December 16, 2021, wherein the Company announced the execution of the Purchase Agreement (the “Agreement”) of CannAmerica’s Colorado licensee, Arsenal Oils and Extracts, LLC (“Arsenal”) and the execution of a Management Agreement by the Company’s wholly owned US subsidiary... Read more
Organigram Makes Additional $2.5 Million Investment in Hyasynth Biologicals, a Leading Cannabinoid Biosynthesis Company
As an early investor in biosynthesis, Organigram Holdings Inc. (NASDAQ: OGI), (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, and Hyasynth Biologicals Inc. (“Hyasynth”) a private biotechnology company and pioneer in the field of cannabinoid science and biosynthesis are pleased to announce that Organigram has acquired an additional $2.5... Read more
Green Stock News
PharmaCielo Announces $15.0 Million Non-Brokered Private Placement of Debenture Units
All amounts expressed in Canadian dollars unless otherwise noted PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. ("Holdings"), today announced that it has plans to issue up to 15,000 debenture units (each a "Unit") in a non-brokered private placement (the... Read more
Green Stock News
MediPharm Labs Receives Award for CBD Brand of the Year
MediPharm Labs pharma-quality CBD dominant oil line has been awarded CBD Brand of the year by KIND Magazine. MediPharm Labs’ CBD products have seen steady revenue growth and notoriety in 2021, including on national television on an episode of CBC Marketplace. MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based... Read more
Organigram Acquires Quebec-Based Laurentian Organic Inc. in Accretive Transaction
Organigram Holdings Inc. (TSX: OGI and NASDAQ: OGI), the parent company of Organigram Inc. (collectively “Organigram” or the “Company”), a leading licensed producer of cannabis, is pleased to announce it has acquired all of the issued and outstanding shares of Laurentian Organic Inc. (“Laurentian”), in a cash and share transaction for aggregate consideration of $36 million, plus earnout consideration (the... Read more
VIVO Cannabis(TM) Announces Appointment of Former President and CEO of Zenabis Global, and Former CFO of Cronos Group, to the Board
VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") is pleased to announce the appointment of Shai Altman and Glen Huber to the board of directors of the Company (the "Board"), effective immediately. "I am very pleased to welcome Mr. Altman and Mr. Huber to the Board of Directors," said Ray Laflamme, Chairman of the Board and Chief Executive Officer of VIVO. "Both Mr. Huber and Mr. Altman have strong... Read more
MediPharm Labs Provides Operational Update and Confirms Profitability Improvement Initiatives are Underway
Strong cash balance and continued reduction of convertible debt to less than $500K. Opportunities for optimization of the operating strategy between Australia and Canada as the Canadian Drug Establishment Licence (DEL) unlocks many manufacturing and supply chain pathways. These pathways will reduce infrastructure cost, improve delivery times, and increase customer satisfaction. Delivery to five international medical... Read more
PharmaTher Provides Update on Product Pipeline and Expected Milestones for 2022
Focused on becoming a leader in the development and commercialization of specialty ketamine prescription-based products Expected milestones for 2022 include initiating Phase 3 clinical study for ketamine to treat Parkinson’s disease (KETLID); completing Phase 2 clinical study for ketamine to treat ALS (KETALS); completing observational study with ketamine and betaine for depression and pain (KETABET); initiating Phase 2... Read more
Tetra Bio-Pharma Announces Closing of $2.1 Million Marketed Public Offering of Units
Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development, is pleased to announce the closing of its marketed public offering (the "Offering") of 13,064,000 units of the Company (the "Units"), at a price of $0.163 per Unit for aggregate gross proceeds of $2.1 million. The Offering was co-led by Research Capital Corporation and... Read more